Articles en Anglais

10th Annual Meeting Catch Up Online until 30th June 2021 10th Annual Meeting Catch Up Online until 30th June 2021 Plenary presentations (plus Q&A) from the 10th Annual Meeting, are available online until 30th June 2021. Presentations from the winners of this year’s Thieves’ Market, Saskia Rowson and Poster Sessions, George Robinson can also be accessed at lupus.academy.  11th

The Antiphospholipid antibody syndrome (« SAPL ») is an autoimmune « disease » characterized  clinically by the occurence of blood clots or miscariages  and biologically by the presence of antibodies directed against phospholipids. Phospholipid are constituent of our  cell membranes. By interacting with some membranes, these antibodies will activate coagulation and cause the appearance of blood clots (thrombosis), which can be located in all body’s blood vessels

THE DISEASE The lupus takes its name from one of its symptoms: skin rash on the face in form of mask called « wolf » (from the Latin lupus). Autoimmune, this chronic inflammatory disease is linked to dysfunction of immune defenses, which turn against the body. The damage can be limitated to scars (face, décolleté, hands) cause joint pains or reach

Systemic Lupus in Men : What feature?       Lupus is rare in men depending on series. There seems to have in men more kidney damage but this is controversial. There also seems to have more neurological manifestations, thrombotic manifestations, cardiovascular, serositis, arthritis, hepatomegaly, infections …. but this is very variable from one series to another.     Tan

The disease is no longer an obstacle Lupus touches in nine cases in ten women aged between20 to 40 years. A long time, this disease forbade them any project of pregnancy because estrogen production increased the risk of flares. Today, this danger is under control and it is most often possible to carry a pregnancy provided to plan it within

Introduction and Epidemiology Atherosclerosis during lupus is an important issue because of its major impact in terms of morbi-mortality and prognosis. The last years are by the understanding of new pathophysiological mechanisms of atherosclerosis in connective which led to new therapeutic concepts. However, several questions remain unanswered about the particular mechanisms responsible for the accelerated

The first National Survey about the prevalence of Lupus in France For the first time, a survey using national data of health (“SNIIRAM and PMSI) allowed to estimate the incidence and prevalence of systemic lupus erythematosus, in France, in respectively 3,32 and 47 case/100 000 year 2010, and 27369 prevalent cases the same year. The